Cancer Emergencies · Patient & Caregiver Guide

Chemotherapy Extravasation

Pain, burning, swelling or leakage around an infusion needs immediate staff attention. Do not wait for the infusion to finish.

Educational information cannot replace emergency assessment. Hospital treatments below describe clinician decisions, not medicines or procedures to perform yourself. Follow your treating team’s personalised emergency plan.

What is this emergency?

Extravasation means a medicine leaks from a vein or device into surrounding tissue. Vesicant medicines can cause blisters and tissue damage; irritants can cause pain and inflammation. Some irritants also have vesicant properties.

Why does it happen?

A cannula may move, a vein may leak, or a central-line or port problem may allow medicine outside the bloodstream. Injury depends on the drug, concentration, amount leaked and time before recognition.

Who is at risk?

It can occur with peripheral cannulas and central devices. Fragile veins, difficult access, impaired sensation or communication and longer infusions can make detection harder. A port reduces some access difficulties but does not eliminate extravasation risk.

Early symptoms

Burning, stinging, pain, swelling, redness, wetness or a change in infusion flow may be early signs. Some injuries are initially subtle. Report a new sensation even when the site looks normal.

Emergency warning signs

Rapid swelling, severe pain, blistering, skin colour changes, loss of sensation or impaired limb movement requires urgent specialist assessment. Pain or swelling around a port, chest or neck during infusion also needs immediate attention.

What should patients do immediately?

Tell infusion staff at once. Staff should stop the infusion immediately and assess the site. At home, use only the emergency stop or clamp steps you have been specifically taught, call the oncology service immediately and do not disconnect the device. Seek emergency care if urgent advice is unavailable or symptoms are severe.

What should patients avoid?

Do not flush, massage, press on or remove the cannula or port needle yourself. Do not apply an automatic hot or cold compress, creams or home remedies. The correct temperature and antidote depend on the medicine, and a wrong choice may worsen injury.

How is it diagnosed?

The team identifies the drug and estimates exposure, examines and documents the affected area and checks the access device. Photographs and repeated assessment track change. A suspected central-device leak may need imaging or a specialist flow study.

How is it treated in hospital?

Trained staff stop administration, initially leave access in place for aspiration of residual drug and do not flush. Subsequent removal or device management is a clinical decision. Drug-specific protocols guide warm or cold applications and antidotes, such as dexrazoxane for selected anthracycline events or hyaluronidase for selected agents. Wound or surgical specialists assess serious injury.

Possible complications

Injury may develop or worsen over days, causing ulceration, infection, scarring, nerve damage or loss of function. Severe cases can need surgery. Mild-looking early skin changes do not guarantee a harmless course.

Prevention and follow-up

Keep follow-up appointments and report increasing pain, blistering, colour change or fever. Follow the exact written site-care plan. For future infusions, keep the site visible when possible and report discomfort immediately; never feel that you are interrupting staff unnecessarily.

Frequently asked questions

Should I remove the needle immediately?

No. Staff may need it to aspirate remaining medicine. Let the clinical team manage the device.

Is an ice pack always correct?

No. Thermal treatment is drug-specific, and some situations need warmth or no compress with a particular antidote.

References

References checked on 15 October 2026. Hospital treatment follows local protocols and individual assessment.